Using Emulsigen-D as Recent Adjuvant in Trivalent Foot and Mouth Disease Vaccine

Walaa Shabana; Ismail; A. Fathy; A.; Hind Mohamed; Mossad; W.

Authors

Walaa Shabana
Ismail
A. Fathy
A.
Hind Mohamed
Mossad
W.

Keywords:

FMD, SNT, ELISA, emulsigen#xAE;-D; montanid ISA 206

Abstract

The immunity and protective capability produced by vaccines can vary remarkably according to the kinds of adjuvant being used. Through this work three formulae of the inactivated trivalent FMD vaccine (O pan Asia, A Iran O5 , and SAT2 / EGY/2012) were prepared using different adjuvants including Emulsigen ® -D; Montanid ISA 206 and Emulsigen ® -D (ED) with aluminum hydroxide gel (ALOH). All of these vaccine formulae were found to be free from foreign contaminants and safe. Also, each vaccine formula was injected in a separate sheep group and serum samples were collected along 38-week post-vaccination for tracing of antibodies against FMDV serotypes by serum neutralization test (SNT) and enzyme-linked immune sorbent assay (ELISA).

Downloads

How to Cite

Using Emulsigen-D as Recent Adjuvant in Trivalent Foot and Mouth Disease Vaccine. (2018). Global Journal of Medical Research, 18(G3), 1-9. https://medicalresearchjournal.org/index.php/GJMR/article/view/1658

Download Citation

References

Min-Eun Park, Seo-Yong Lee, Rae-Hyung Kim, Mi-Kyeong Ko, Jeong-Nam Park, Kwang-Nyeong Lee, Su-Mi Kim, Joo-Hyung Choi, Su-Hwa You, Byounghan Kim, Jong-Soo Lee, Jong-Hyeon Park (2016) Altered adjuvant of foot-and-mouth disease vaccine improves immune response and protection from virus challenge. 5, 97-104.

R Kitching (1999) Foot-and-mouth disease: current world situation. 17(13-14), 1772-1774.

R Meyer, R Knudsen (2001) Foot-and-mouth disease: a review of the virus and the symptoms. 64, 21-23.

T Doel, P Baccarini (1981) Thermal stability of foot-and-mouth disease virus. 70(1), 21-32.

P Barnett, H Carabin (2002) A review of emergency foot-and-mouth disease (FMD) vaccines. 20(11-12), 1505-1514.

P Satya (2009) Vaccination against foot-and-mouth disease virus: Strategies and effectiveness. 8(3), 347-365.

H Aidaros (2002) Regional status and approaches to control and eradication of foot and mouth disease in the Middle East and North Africa. 21(3), 451-458.

Abd El-Rahman, A Farag, M El-Kilany, S Ali, S Yazed, M (2006) Isolation and identification of serotype O of foot and mouth disease virus from imported bulls and its correlation to the current used vaccine strain O1/3/1993. 91-100.

Abd El-Aty, S Fakry, H Hind, M El-Sayed, E Wael, M Rizk, S Abu-Elnaga, H Mohamed, A, Abd El-Kreem, A Farouk, E (2013) Isolation and Molecular characterization of foot and mouth disease sat2 virus during outbreak 2012 in Egypt. 3(2), 60-68.

M Technologies, Emulsigen (2012) Unknown Title.

E El-Sayed, Gamal, Hassan, Mahdy Hegazy, A Abdel-Atty, M (2015) Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine. 8(10), 1189-1198.

E Hiszczynska-Sawicka, H Li, J Xu, G Oledzka, J Kur, R Bickerstaffe (2010) Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. 124, 365-372.

Manpreet Kaur, Ankur Saxena, Anant Rai, Rakesh Bhatnagar (2010) Rabies DNA vaccine encoding lysosome‐targeted glycoprotein supplemented with Emulsigen‐D confers complete protection in preexposure and postexposure studies in BALB/c mice. 24(1), 173-183.

R Gupta (1998) Aluminum compounds as vaccine adjuvants. 32(3), 155-172.

Anne-Cécile Rimaniol, Gabriel Gras, François Verdier, Francis Capel, Vladimir Grigoriev, Fabrice Porcheray, Elisabeth Sauzeat, Jean-Guy Fournier, Pascal Clayette, Claire-Anne Siegrist, Dominique Dormont (2004) Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type. 22(23-24), 3127-3135.

Hanfen Li, Suba Nookala, Fabio Re (2007) Aluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release. 178(8), 5271-5276.

L Reed, H Muench (1938) A simple method of estimating 50% end points. 27, 493-497.

Peter Glavič (2009) Special Issue: Feature Papers to Celebrate the Inaugural Issue of Standards. 1(1), 17-18.

H Xuan, Y Li, H Fang, C Zheng (2011) Establishment of persistent infection with foot and mouth disease virus in BHK21 cells. 8, 169.

S Barteling, R Woortmeyer (2004) Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine. 80(2-3), 103-117.

A Ismail, S El-Mahdy, W Mossad, Abd El-Krim, A Abou El-Yazid, M Ali, S (2013) Optimization of the inactivation process of FMD virus serotype SAT-2 by Binary Ethyleneimine (BEI). 3(3), 117-124.

Shiro Yoshimura (2017) Report on FAO/OIE Global Conference on Foot and Mouth Disease Control. 16(2), 160-161.

Mev Ferreira (1976) Au-delà de la crise. 21-22.

A Voller, D Bidwell, A Bartlett, D Fleck, M Perkins, B Oladehin (1976) A microplate enzyme-immunoassay for toxoplasma antibody.. 29(2), 150-153.

L Rodriguez, M Grubman (2009) Foot and mouth disease virus vaccines. 27, 90-94.

P Hunter (1998) Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa. 16, 261-264.

Pamela Hunter (1998) Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa. 16(2-3), 261-264.

Pervaiz Dar, Ramya Kalaivanan, Nuru Sied, Bedaso Mamo, Subodh Kishore, V Suryanarayana, Ganesh Kondabattula (2013) Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle. 31(33), 3327-3332.

Elżbieta Hiszczyńska-Sawicka, Hong Li, Janet Xu, Gabriela Olędzka, Józef Kur, Roy Bickerstaffe, Mirosław Stankiewicz (2010) Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. 124(4), 365-372.

Rajesh Gupta, Bradford Rost, Edgar Relyveld, George Siber (1995) Adjuvant Properties of Aluminum and Calcium Compounds. 6, 229-248.

V Reddy, Srinivasan (1997) Performance of aluminium hydroxide gel and oil adjuvant rabies vaccines in bovines. 286, 523-526.

James Brewer, Margaret Conacher, Abhay Satoskar, Horst Bluethmann, James Alexander (1996) In interleukin‐4‐deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production. 26(9), 2062-2066.

Min-Eun Park, Seo-Yong Lee, Rae-Hyung Kim, Mi-Kyeong Ko, Kwang-Nyeong Lee, Su-Mi Kim, Byoung-Kwan Kim, Jong-Soo Lee, Byounghan Kim, Jong-Hyeon Parka (2014) Enhanced immune responses of foot and mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats. 32, 5221-5227.